Group items tagged

'Institut national de la recherche scientifique (INRS) a dévoilé jeudi les résultats d'une étude sur les pratiques culturelles des jeunes Montréalais. Le premier constat : les jeunes sont à la fois consommateurs et producteurs de culture.

"Facebook (FB) CEO Mark Zuckerberg is taking a page from Fed Chairman Ben Bernanke's playbook by notifying the SEC that he will not sell any of his shares in the social network for at least 12 months. This announcement is an attempt to put a floor on the decline of Facebook's stock, in what is essentially a passive, one year stock buyback which targets the Nov. 14 lockup expiration, when 1.2 billion new shares were scheduled to come to market."

MakerBot Industries, creators of the Replicator 3D printer that hit stores this past January have just upgraded their award-winning printer. The Replicator 2 has increased resolution, can print larger objects, and sports a stylish new look. And the new printer is only one way MakerBot is making a serious bid to become a major competitor in the growing 3D printing market. Just days ago the company announced the grand opening of their first retail store, located in the NoHo neighborhood of Manhattan.

"The transformation of the nation's news landscape has already taken a heavy toll on print news sources, particularly print newspapers. But there are now signs that television news - which so far has held onto its audience through the rise of the internet - also is increasingly vulnerable, as it may be losing its hold on the next generation of news consumers."

We have had some big successes with digital medicine. In my field about six years ago, device companies started putting antennas into implanted devices. We now analyze data from those devices in more than 200,000 patients. We've collected information on 20 million device downloads, recorded 150,000 life-saving interventions, and collected millions of pieces of valuable additional data. The numbers were clear. Here is what we've learned: If you open up this implanted device to the network, people live longer. We live longer and healthier lives when our health is continuously monitored by a device and exceptions to normal health are reported by the device to our caregivers. The technology exists and is often very inexpensive. It keeps people out of hospitals; saving money and lives. We've proven that. So why aren't we doing more monitoring? It's not a regulatory problem or a lack-of-vision problem in the medical and technology companies; it's that there's too much perceived risk in changing the medical structure.